LOS ANGELES–(BUSINESS WIRE)–Forcyte Biotechnologies, a tech-enabled drug discovery company targeting diseases of mechanobiology, has secured new funding from Milestone View, Pioneer Fund, Acequia Capital, Y Combinator, Jude Gomila (CEO, Golden), …
The Body is (also) a Mechanical System
The human body is as much a mechanical system as it is an electrical and a chemical one and disruption of normal mechanical function in cells & tissue leads to diseases – some of the biggest in the world!
We are charting human mechanobiology to discovery better drugs, faster.
Our proprietary wet-lab/dry-lab platform is the first high-throughput bio-interrogation system providing precise functional cell contractility (force-generation) data using standard assay formats.
Millions of datapoint at a time, we are compiling the largest mechanobiology dataset, connecting biology, chemistry, tissue-type, and kinetics to inform discovery of novel drug targets and development of effective drugs.
Forcyte has been awarded a $1.5M phase 2 SBIR to continue developing functional assays for cellular contractility to support programs in respiratory, hypertension, and many other indications where cellular force …
The collaborative App Note can be requested directly from Molecular Devices. Collaborative Poster Inquiries may be directed to email@example.com. Free assay samples are available! Download App Note Here!